News
Despite advice to shop around before selecting a plan, consumers may find that getting answers about drug coverage can be an exercise in frustration, despite a federal health law requirement that insurers provide lists of the prescription medications included in their plans.
Two professional organizations representing emergency doctors warn that a new federal rule could lead to higher out-of-pocket costs for consumers when they need emergency care outside their health plan's network of providers. But consumer advocates and health policy experts say the groups' proposed solution doesn't adequately protect consumers.
A blanket hardship exception from 2015's meaningful use reimbursement penalties passed both the House and Senate last week as part of the Patient Access and Medicare Protection Act, offering providers wider latitude for securing exemptions from possible fines.
Paul DePodesta, the man who brought 'Moneyball' to Major League Baseball, just joined Scripps Translational Science Institute, where he will use his data-analyzing prowess to hopefully transform medicine.
As prescription drug prices continue to drive up healthcare spending, the Centers for Medicare and Medicaid Services is creating a new online dashboard to increase transparency and address affordability. Read the story for the full price breakdown.
The Federal Trade Commission has moved to block a proposed merger of Advocate Health Care Network and NorthShore University HealthSystem, a decision the Chicago providers said they would fight.
CMS said 540 drugs had a 25-percent increase for $13.7 billion, or 11 percent of program costs.
Well-known healthcare investment firm OrbiMed has closed a major new venture capital fund, OrbiMed Private Investments VI, with $950 million in limited partner commitments, the company announced in a statement.
WellCare Health Plans, an agency focused on providing government-sponsored managed care services, has given $13,500 in micro-grants to organizations across the state of New York.
Former Turing Pharmaceutical CEO Martin Shkreli, who was arrested last week on charges of securities fraud and who has been reviled for hiking the price of a life-saving drug by 5,000 percent, has been terminated as CEO of KaloBios, the company announced Monday.